Evidence map›Paper›PMID 21716301›Full record

ArticleGene therapy2012

Muscle gene electrotransfer is increased by the antioxidant tempol in mice.

B Markelc, G Tevz, M Cemazar, S Kranjc, J Lavrencak, B Zegura, J Teissie, G Sersa

Open access · hybridAbstract read
In one paragraph

Article in Gene therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Gene electrotransfer enhanced by nanosecond pulsed electric fields.Molecular therapy. Methods & clinical development · 2014
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

B MarkelcDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
G Tevz
M Cemazar
S Kranjc
J Lavrencak
B Zegura
J Teissie
G Sersa
Institute of Oncology Ljubljana · SIInstitut de Pharmacologie et de Biologie Structurale · FRNational Institute of Biology · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electropermeabilization (EP) is an effective method of gene transfer into different tissues. During EP, reactive oxygen species (ROS) are formed, which could affect transfection efficiency. The role of generated ROS and the role of antioxidants in electrotransfer in myoblasts in vitro and in Musculus tibialis cranialis in mice were, therefore, investigated. We demonstrate in the study that during EP of C2C12 myoblasts, ROS are generated on the surface of the cells, which do not induce long-term genomic DNA damage. Plasmid DNA for transfection (pEGFP-N1), which is present outside the cells during EP, neutralizes the generated ROS. The ROS generation is proportional to the amplitude of the electric pulses and can be scavenged by antioxidants, such as vitamin C or tempol. When antioxidants were used during gene electrotransfer, the transfection efficiency of C2C12 myoblasts was statistically significantly increased 1.6-fold with tempol. Also in vivo, the transfection efficiency of M. tibialis cranialis in mice was statistically significantly increased 1.4-fold by tempol. The study indicates that ROS are generated on cells during EP and can be scavenged by antioxidants. Specifically, tempol can be used to improve gene electrotransfer into the muscle and possibly also to other tissues.

Indexed as

Gene Transfer TechniquesAnimalsAntioxidantsCell LineCell SurvivalCyclic N-OxidesElectroporationFemaleMiceMice, Inbred C57BLMuscle, SkeletalMyoblastsPlasmidsReactive Oxygen SpeciesSpin LabelsAntioxidantsCyclic N-OxidesReactive Oxygen SpeciesSpin Labelstempol

Identifiers

PMID21716301
PMCPMC3298856
OpenAlexW1983587932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.